Computational drug delivery

Advanced Drug Delivery Reviews

Volumn 58, Issue 12-13, 2006, Pages 1271-1273

  Haworth, Ian S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; COMPUTER SIMULATION; DRUG DELIVERY SYSTEM; DRUG METABOLISM; DRUG SOLUBILITY; DRUG TARGETING; EDITORIAL; INTESTINE MUCOSA PERMEABILITY; LIPID BILAYER; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SIMULATION; THERMODYNAMICS;

COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; HUMANS; MODELS, BIOLOGICAL; PHARMACOKINETICS;

EID: 33751193464     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2006.09.003     Document Type: Editorial

References (18)

1. Sousa S.F., Fernandes P.A., and Ramos M.J. Protein-ligand docking: current status and future challenges. Proteins 65 (2006) 15-26
2. Lorber D.M., and Shoichet B.K. Hierarchical docking of databases of multiple ligand conformations. Curr. Top. Med. Chem. 5 (2005) 739-749
3. Guner O.F. The impact of pharmacophore modeling in drug design. IDrugs 8 (2005) 567-572
4. Stoermer M.J. Current status of virtual screening as analysed by target class. Med. Chem. 2 (2006) 89-112
5. Douguet D., Chen H.C., Tovchigrechko A., and Vakser I.A. DOCKGROUND resource for studying protein-protein interfaces. Bioinformatics (Aug 23 2006) (Electronic publication ahead of print)
6. van Dijk A.D., and Bonvin A.M. Solvated docking: introducing water into the modelling of biomolecular complexes. Bioinformatics (Aug 9 2006) (Electronic publication ahead of print)
7. Agoram B., Woltosz W.S., and Bolger M.B. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv. Drug Deliv. Rev. 50 Suppl 1 (2001) S41-S67
8. Pozzan A. Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery. Curr. Pharm. Des. 12 (2006) 2099-2110
9. Balakin K.V., Savchuk N.P., and Tetko I.V. In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions. Curr. Med. Chem. 13 (2006) 223-241
10. Stenberg P., Bergstrom C.A., Luthman K., and Artursson P. Theoretical predictions of drug absorption in drug discovery and development. Clin. Pharmacokinet. 41 (2002) 877-899
11. Bergstrom C.A. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption. Basic Clin. Pharmacol. Toxicol. 96 (2005) 156-161
12. Schuster D., Steindl T.M., and Langer T. Predicting drug metabolism induction in silico. Curr. Top. Med. Chem. 6 (2006) 1627-1640
13. Stefanovski D., Moate P.J., and Boston R.C. WinSAAM: a windows-based compartmental modeling system. Metabolism 52 (2003) 1153-1166
14. Martonen T.B., Smyth H.D., Isaacs K.K., and Burton R.T. Issues in drug delivery: concepts and practice. Respir. Care 50 (2005) 1228-1252
15. Miller R., Ewy W., Corrigan B.W., Ouellet D., Hermann D., Kowalski K.G., Lockwood P., Koup J.R., Donevan S., El-Kattan A., Li C.S., Werth J.L., Feltner D.E., and Lalonde R.L. How modeling and simulation have enhanced decision making in new drug development. J. Pharmacokinet. Pharmacodyn. 32 (2005) 185-197
16. van de Waterbeemd H. From in vivo to in vitro/in silico ADME: progress and challenges. Expert Opin. Drug Metab. Toxicol. 1 (2005) 1-4
17. Willmann S., Lippert J., and Schmitt W. From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools. Expert Opin. Drug Metab. Toxicol. 1 (2005) 159-168
18. Ishii N., Robert M., Nakayama Y., Kanai A., and Tomita M. Toward large-scale modeling of the microbial cell for computer simulation. J. Biotechnol. 113 (2004) 281-294